AceLink Therapeutics

Ace Link Therapeutics

Pharmaceuticals, Eureka Dr Ste 151, Newark, , 94560, California, 39600, United States, 1-10 Employees

acelinktherapeutics.com

  • LinkedIn

phone no Phone Number: 65********

Who is ACELINK THERAPEUTICS

AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associa...

Read More

map
  • 39600 Eureka Dr Ste 151, Newark, California, 94560, United States Headquarters: 39600 Eureka Dr Ste 151, Newark, California, 94560, United States
  • 2019 Date Founded: 2019
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ACELINK THERAPEUTICS

AceLink Therapeutics Org Chart and Mapping

Employees

Michael Babcock

Vice President, Research & Early Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AceLink Therapeutics

Answer: AceLink Therapeutics's headquarters are located at Eureka Dr Ste 151, Newark, , 94560, California, 39600, United States

Answer: AceLink Therapeutics's phone number is 65********

Answer: AceLink Therapeutics's official website is https://acelinktherapeutics.com

Answer: AceLink Therapeutics's revenue is $1 Million to $5 Million

Answer: AceLink Therapeutics's SIC: 2836

Answer: AceLink Therapeutics's NAICS: 325414

Answer: AceLink Therapeutics has 1-10 employees

Answer: AceLink Therapeutics is in Pharmaceuticals

Answer: AceLink Therapeutics contact info: Phone number: 65******** Website: https://acelinktherapeutics.com

Answer: AceLink Therapeutics is a startup biopharmaceutical company located in the San Francisco Bay Area. Our mission is to develop first-in-class and best-in-class drugs for genetically associated human diseases with the initial focus on a small molecule drug for polycystic kidney disease (PKD), a human genetic disease with 12 million patients worldwide.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access